Clinical trial for prostate cancer awarded 2020 ACTA Trial of The Year
The Australian Clinical Trials Alliance (ACTA) has recognised the remarkable Australians who advance the health…
Browsing: ENZAMET trial
ASCO 2019: Adding enzalutamide to standard first-line treatment improves survival for men with metastatic hormone-sensitive prostate cancer
An interim analysis of the international randomised, phase III ENZAMET trial found that 80% of…